Status:
COMPLETED
Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Vocal Fold Nodules
Muscle Tension Dysphonia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients with vocal hyperfunction will undergo standard of care voice therapy with ambulatory voice monitoring before therapy and after the first 3 voice therapy sessions. Biofeedback will be added to...
Detailed Description
This study will use a single subject design to determine if adding ambulatory voice biofeedback to conventional voice therapy can result in faster carryover (generalization) of new vocal behaviors est...
Eligibility Criteria
Inclusion
- Patients with vocal fold nodules or muscle tension dysphonia undergoing voice therapy
Exclusion
- If a patient's baseline ambulatory monitoring data is not at least 1 standard deviation away from a normative database in any measure, he/she will be excluded. Non-English speakers are excluded because prompts on the smartphone app are only available in English.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2024
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03416868
Start Date
June 1 2018
End Date
February 5 2024
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital - Center for Laryngeal Surgery and Voice Rehabilitation
Boston, Massachusetts, United States, 02114